Cancer prevention with semi-allogeneic ES cell-derived dendritic cells
Authors:
- Hidetake MatsuyoshiHMHidetake Matsuyoshi
- Shinya HirataSHShinya Hirata
- Akari KurisakiAKAkari Kurisaki
- Yutaka MotomuraYMYutaka Motomura
- Yoshihiro YoshitakeYYYoshihiro Yoshitake
- Masanori ShinoharaMSMasanori Shinohara
- Yasuharu NishimuraYNYasuharu Nishimura
- Satoru SenjuSSSatoru Senju
- 1 September 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 335 (1) , 5-13
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Uehara Memorial Foundation
- Tokyo Biochemical Research Foundation
This publication has 26 references indexed in Scilit:
- The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cellsEuropean Journal of Immunology, 2005
- Identification of Glypican-3 as a Novel Tumor Marker for MelanomaClinical Cancer Research, 2004
- Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray AnalysisClinical Cancer Research, 2004
- A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cellsNature Immunology, 2004
- Dendritic cells: a journey from laboratory to clinicNature Immunology, 2004
- Generation and genetic modification of dendritic cells derived from mouse embryonic stem cellsBlood, 2003
- Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumorsProceedings of the National Academy of Sciences, 2001
- An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrowJournal of Immunological Methods, 1999
- A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screeningProceedings of the National Academy of Sciences, 1997
- Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunityNature Medicine, 1995